3-T1AM is a potential therapeutic agent for suppressing UM expansion as already indicated in other studies demonstrating that this thyroid hormone metabolite reduces cancer cell growth and viability (Rogowski et al., 2017; Shinderman-Maman et al., 2017). This evidence concerns the gene TG and cancer.